Integrated Workflow Solutions from ZEISS Create Digital Transformation in Healthcare

The fully connected environment, digital technologies and artificial intelligence tools help optimize patient care.

JENA, Germany and DUBLIN, August 30, 2022 /CNW/ — ZEISS Medical Technology continues to build on its leadership in digital solutions by exploring new ways to advance the future of transformative eye care. To ZEISS Innovation Week, September 6-8, 2022ZEISS Medical Technology will host leading ophthalmology experts to share their personal experiences on how the power of integrated workflow solutions, data management and a range of new software applications are helping to improve efficiency and optimization of patient care.

ZEISS will also be exhibiting at European Society of Cataract and Refractive Surgeons (ESCRS) Annual meeting, September 16-20and the American Academy of Ophthalmology (AAO) Conference, September 30October 3offering demonstrations, educational programs and scientific events on how digital technologies can support clinical efficiency and improve patient outcomes.

“As a leader in digital solutions, ZEISS is setting the standard for new ways to manage care at scale. The use of data insights and workflow solutions integrated with artificial intelligence adds value to managing disease progression and optimizing clinical practices,” said Euan S. ThomsonPhD, President of Ophthalmic Devices and Head of Digital Business at Carl Zeiss Meditec, Inc. “We continue to focus on developing digital solutions that create the roadmap needed to improve care.”

“Digital workflow is the backbone of a practice as it integrates all diagnostics, therapeutics, gives peace of mind and less stress to the clinician and surgeon,” said Sri GaneshaMD, President and CEO of Nethradhama Hospital, India. “At the end of the day, that’s what you want to see – efficiency, safety, more patients that can be accommodated, and better outcomes.”

“Our workflow is completely integrated, we’re 100% paperless and everything talks to each other,” said Bruce A. RiversMD, Envue Eye & Laser Center, MarylandUS “The benefits of this integrated workflow are happy staff, less work for everyone involved, and everything runs much more smoothly, reducing time, stress, and ultimately improving the patient experience.”

Not all products, services or offerings are endorsed or offered in all markets and approved labeling and instructions may vary by country. For country-specific product information, see the appropriate country website. Product specifications may change in design and scope of delivery due to ongoing technical development.

www.zeiss.com/newsroom

Brief profile
Carl Zeiss Meditec AG (ISIN: DE 0005313704), which is listed on the German Stock Exchange MDAX and TecDAX, is one of the world’s leading medical technology companies. The Company provides innovative technologies and application-driven solutions designed to help physicians improve the quality of life of their patients. The Company offers complete solutions, including implants and consumables, for diagnosing and treating eye diseases. The Company creates innovative visualization solutions in the field of microsurgery. With 3,290 employees worldwide, the Group generated revenue of €1,335.5 million during the 2019/20 financial year (at September 30, 2020).

The Group’s head office is located in Jena, Germanyand has subsidiaries in Germany and abroad; more than 50 percent of its employees are based in the UNITED STATES, Japan, Spain and France. The Center for Application and Research (CARIn) of Bengaluru, India and the Carl Zeiss Innovations Research and Development Center in Shanghai, China, strengthen the Company’s presence in these developing economies. Approximately 41% of the shares of Carl Zeiss Meditec AG are free float. The rest approx. 59% are held by Carl Zeiss AG, one of the world’s leading groups in the optics and optoelectronics industries.

For more information visit: www.zeiss.com/med

SOURCE Carl Zeiss Meditec AG

For further information: Investor Contact: Sebastian Frericks, Director Investor Relations, Carl Zeiss Meditec AG, Telephone: +49 3641 220 116, Mail: [email protected]Press Contact: Laurie Ferguson, Head of Global Communications Ophthalmic Devices, Carl Zeiss Meditec, Phone: +1 925 719 7825, Mail: [email protected]